UT-AKI

UT-AKI predicts the risk of acute kidney injury (AKI) in ST-elevation myocardial infarction (STEMI) patients to inform clinical risk assessment.

Key Features:

• Prediction Accuracy: Demonstrates superior sensitivity and overall predictive capability compared to existing indices, with area under the curve (AUC) of 0.76 for distinguishing patients who will develop AKI.
• Clinical Relevance: Developed from a racially diverse cohort of 1,144 consecutive STEMI patients, identifying Stage ≥1 AKI in 12.9% and Stage 2–3 AKI in 2.9%, with AKI associated with 5.7-fold unadjusted increased mortality, 2.5-fold longer hospital stay, systolic dysfunction, elevated left ventricular end-diastolic pressures, hypotension, and need for intra-aortic balloon counterpulsation.
• Internal Validation: The algorithm underwent internal validation within the study cohort.

Scientific Applications:

• Risk Stratification: Identifies patients at increased risk of AKI post-STEMI to enable stratification for intensified monitoring and management.
• Tailored Interventions: Provides predictive information to support customization of diagnostic and therapeutic strategies aimed at mitigating AKI onset and complications.
• Resource Allocation: Predicts likelihood of prolonged hospital stay to inform planning and allocation of healthcare resources.

Methodology:

The algorithm was derived by analyzing clinical data from a racially diverse cohort of 1,144 consecutive STEMI patients and correlating clinical parameters with AKI incidence and severity, with internal validation performed within the cohort.